Clinical Scientist Development Award
The 2021 Clinical Scientist Development Awards competition is now closed to pre-proposal submissions. Applicants will be notified if they will advance to the next stage of competition by Jan. 15, 2021 at 5 p.m. ET. For applicants advancing to the next stage, full proposals will be due on March 12, 2021 at 3 p.m. ET. Funding recommendations will be shared with applicants by the end of May 2021.
The Doris Duke Clinical Scientist Development Award provides grants to junior physician scientists to facilitate their transition to independent clinical research careers.
Rationale & History
The transition to an independent research career is often more difficult for physician scientists than it is for other researchers, as these individuals must balance the demands of both seeing patients and conducting research. DDCF's Medical Research Program created the Clinical Scientist Development Award to provide mentored research funding to early-career physician-scientist faculty to enable their transition to independent and successful research careers. In 2020, the Medical Research Program awarded 17 grants to investigators working in a broad range of disease areas.
Since the beginning of the program in 1998, the foundation has awarded 337 Clinical Scientist Development Awards totaling over $152 million.
The Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years. The priority of the CSDA program is to fund outstanding individuals with potential for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities based on disease area or research type.
In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or tissues derived from animals, including cell lines, will not be supported by this program.
To receive announcements about future competitions for this and other programs, please subscribe to our listserv.